Saturday 17 October 2026
Export GKOS’s income statement to Excel — free account
Glaukos Corporation
GKOS Healthcare Medical Devices
Glaukos Corporation’s revenue for fiscal 2025 (year ended December 2025) was $507.4 million, up 32.3% from fiscal 2024. In the quarter to June 2026, revenue grew 49.5%, EPS grew 8.82%, free cash flow grew 211.8% and total debt fell 2.15%, each against the same quarter a year earlier. Revenue growth for three consecutive years.
164.84
0.76
−0.46%
Follow GKOS
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
253.15 | 0.00 | 0.00 | 160.21 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Piotroski F-Score |
7 | 5 | 4 | 2 | 2 | 5 | 1 | 3 | 4 | 3 |
P/S ratio |
9.71 | 5.85 | 10.94 | 8.59 | 14.89 | 7.02 | 7.36 | 11.86 | 20.63 | 12.73 |
Altman Z-Score |
39.51 | 19.33 | 36.08 | 8.48 | 5.83 | 2.85 | 2.44 | 4.23 | 22.21 | 15.20 |
P/FCF ratio |
184.10 | 47.07 | 232.05 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Altman Z″-Score (non-manufacturers) |
7.79 | 6.23 | 6.49 | 5.35 | 2.98 | 2.63 | 1.55 | 0.26 | 3.06 | 0.74 |
Beneish M-Score |
(2.05) | (3.28) | (2.64) | 2.81 | (3.28) | (2.90) | (2.73) | (2.79) | (2.26) | (2.96) |
P/Operating CF |
338.72 | 74.71 | 115.82 | (485.50) | 315.81 | (443.57) | (503.35) | (350.04) | 15,601.75 | 943.64 |
P/B ratio |
9.47 | 6.74 | 11.41 | 3.02 | 5.02 | 3.51 | 3.93 | 8.08 | 10.31 | 9.84 |
Price to Tangible BV |
10.03 | 6.89 | 11.44 | 9.06 | 13.75 | 10.96 | 13.35 | 33.13 | 18.09 | 14.43 |
EV/Sales |
8.90 | 5.12 | 10.19 | 8.11 | 14.21 | 7.76 | 8.35 | 12.93 | 20.71 | 12.86 |
EV/EBITDA |
111.01 | 253.28 | 0.00 | 0.00 | 0.00 | 577.48 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Operating CF |
82.73 | 31.27 | 97.92 | (5,206.45) | (139.01) | 92.32 | (71.40) | (70.47) | (129.49) | (441.27) |
EV/FCF |
168.84 | 41.25 | 216.06 | (377.22) | (106.79) | (98.86) | (37.38) | (52.18) | (117.49) | (167.07) |
Quick Ratio |
6.50 | 5.06 | 5.24 | 3.68 | 8.86 | 7.06 | 5.37 | 4.53 | 5.05 | 3.82 |
Current Ratio |
7.09 | 5.58 | 5.81 | 4.56 | 9.45 | 7.67 | 6.13 | 5.34 | 5.99 | 4.69 |
Net Debt/EBITDA |
(10.45) | (36.95) | 19.98 | 3.14 | 2.67 | (15.53) | (0.02) | (0.64) | 2.91 | 1.31 |
Debt/Assets |
0.00% | 0.00% | 0.00% | 7.14% | 24.87% | 33.60% | 35.27% | 37.57% | 7.13% | 7.62% |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.09 | 0.37 | 0.60 | 0.67 | 0.77 | 0.09 | 0.10 |
Asset Turnover |
0.91 | 1.06 | 0.97 | 0.46 | 0.25 | 0.29 | 0.28 | 0.32 | 0.40 | 0.54 |
Operating CF/Net income |
2.72 | (283.60) | (1.46) | (0.02) | 0.19 | (0.50) | 0.33 | 0.43 | 0.42 | 0.08 |
Capex/Depreciation |
(1.27) | (1.15) | (1.73) | (0.35) | (0.11) | (1.30) | (0.79) | (0.54) | (0.17) | (0.62) |
Interest Coverage |
4.77 | (1.66) | (5.77) | (19.61) | (8.75) | (2.46) | (6.00) | (9.44) | (12.19) | (43.06) |
| 4.26% | (0.07%) | (8.30%) | 3.64% | (17.95%) | (7.91%) | (17.76%) | (27.16%) | (23.83%) | (26.38%) | |
| 3.60% | (0.06%) | (6.95%) | 3.01% | (13.20%) | (4.83%) | (9.67%) | (13.86%) | (15.29%) | (20.09%) | |
ROIC |
12.37% | (7.43%) | (24.35%) | (5.64%) | (15.05%) | (3.91%) | (9.69%) | (15.48%) | (14.78%) | (28.00%) |
Return on Tangible Assets |
4.09% | (0.07%) | (7.83%) | 6.79% | (27.12%) | (10.09%) | (21.29%) | (31.71%) | (30.98%) | (38.54%) |
Average Days of Receivables |
45.64 | 38.17 | 37.60 | 59.17 | 58.51 | 41.51 | 46.55 | 46.22 | 57.82 | 78.12 |
Research and Development Expense of Revenue |
25.55% | 24.43% | 27.40% | 28.82% | 37.96% | 34.35% | 47.12% | 45.68% | 39.29% | 29.68% |
Selling, General and Administrative Expense of Revenue |
56.61% | 60.44% | 65.94% | 74.53% | 76.19% | 60.97% | 68.20% | 71.20% | 68.10% | 65.38% |
Intangible Assets out of Total Assets |
0.05 | 0.02 | 0.00 | 0.55 | 0.42 | 0.38 | 0.37 | 0.37 | 0.34 | 0.23 |
Share Based Compensation of Revenue |
7.68% | 11.05% | 14.18% | 15.36% | 20.66% | 10.25% | 13.63% | 13.83% | 13.09% | 12.46% |
Graham Net Nets |
0.09 | 0.13 | 0.07 | 0.06 | 0.04 | 0.01 | (0.01) | (0.02) | 0.03 | 0.04 |
Graham Number |
3.27 | 0.00 | 0.00 | 11.74 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Earnings Yield |
0.40% | 0.00% | (0.66%) | 0.62% | (3.63%) | (2.43%) | (4.76%) | (3.61%) | (1.91%) | (2.89%) |
Free Cash Flow Yield |
0.54% | 2.12% | 0.43% | (0.25%) | (0.89%) | (1.12%) | (3.04%) | (2.09%) | (0.85%) | (0.60%) |
Revenue per Share |
3.47 | 4.63 | 5.13 | 6.34 | 5.06 | 6.33 | 5.96 | 6.50 | 7.27 | 8.87 |
Operating CF per Share |
0.37 | 0.76 | 0.53 | (0.01) | (0.52) | 0.53 | (0.70) | (1.19) | (1.16) | (0.26) |
Capex per Share |
(0.19) | (0.18) | (0.29) | (0.13) | (0.16) | (1.03) | (0.63) | (0.42) | (0.12) | (0.42) |
Free Cash Flow per Share |
0.18 | 0.58 | 0.24 | (0.14) | (0.67) | (0.50) | (1.33) | (1.61) | (1.28) | (0.68) |
Cash per Share |
2.91 | 3.46 | 3.98 | 4.66 | 9.09 | 8.92 | 7.43 | 6.10 | 6.05 | 4.87 |
Shareholders Equity per Share |
3.56 | 4.02 | 4.92 | 18.02 | 15.00 | 12.65 | 11.17 | 9.53 | 14.54 | 11.47 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
3.56 | 4.02 | 4.92 | 18.02 | 15.00 | 12.65 | 11.17 | 9.53 | 14.54 | 11.47 |
Free Cash Flow |
6.03 | 19.78 | 8.55 | (5.09) | (29.92) | (23.07) | (63.20) | (78.01) | (67.58) | (39.06) |
Working Capital |
103.09 | 122.67 | 146.20 | 205.18 | 419.74 | 422.77 | 371.50 | 321.45 | 374.67 | 373.71 |
Capital Expenditures |
(6.28) | (6.31) | (10.31) | (4.72) | (6.93) | (47.78) | (30.11) | (20.25) | (6.26) | (24.27) |
Net Current Asset Value |
102.93 | 121.83 | 143.46 | 117.75 | 131.39 | 23.58 | (28.52) | (83.19) | 241.97 | 237.65 |
EV/EBIT |
240.11 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
0.05 | 0.04 | 0.06 | 0.02 | 0.03 | 0.16 | 0.11 | 0.06 | 0.02 | 0.05 |
Price to Operating Income |
261.81 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.65 | 0.47 | 0.31 | 0.61 | 2.74 | 0.53 | 0.40 | 0.36 | 0.37 | 0.35 |
Cash ROIC |
2.83% | 7.69% | 2.72% | (0.56%) | (2.26%) | (1.70%) | (5.11%) | (7.02%) | (5.85%) | (3.89%) |
Accounts Receivable Turnover |
10.47 | 10.29 | 10.26 | 8.30 | 6.04 | 8.46 | 8.14 | 8.29 | 7.62 | 5.99 |
Accounts Payable Turnover |
4.91 | 4.57 | 4.00 | 6.40 | 18.07 | 11.39 | 6.35 | 5.43 | 7.11 | 5.94 |
Inventory Turnover |
2.96 | 2.33 | 2.05 | 1.38 | 3.14 | 3.43 | 2.27 | 1.89 | 1.89 | 1.84 |
Average Days of Payables |
66.94 | 108.27 | 91.50 | 54.68 | 17.39 | 40.17 | 76.21 | 64.91 | 50.57 | 80.38 |
Days of Inventory on Hand |
154.42 | 194.59 | 193.34 | 402.74 | 62.91 | 126.06 | 200.23 | 202.78 | 223.90 | 207.50 |
Average Receivables |
10.93 | 15.48 | 17.66 | 28.55 | 37.24 | 34.75 | 34.76 | 37.96 | 50.30 | 84.68 |
Average Payables |
3.30 | 4.61 | 6.27 | 6.03 | 5.08 | 5.85 | 10.87 | 13.92 | 13.23 | 18.83 |
Average Inventory |
5.47 | 9.03 | 12.25 | 27.93 | 29.19 | 19.41 | 30.43 | 39.91 | 49.83 | 60.62 |
Average Assets |
125.52 | 150.10 | 186.40 | 512.69 | 911.95 | 1,027.60 | 1,026.04 | 971.40 | 957.59 | 934.12 |
Average Common Equity |
106.23 | 127.74 | 156.03 | 423.57 | 670.36 | 627.30 | 558.58 | 495.89 | 614.35 | 711.54 |
Columns are period end dates